These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 28656746
21. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy. Mahabaleshwarkar R, Gohs F, Mulder H, Wilkins N, DeSantis A, Anderson WE, Ejzykowicz F, Rajpathak S, Norton HJ. Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692 [Abstract] [Full Text] [Related]
22. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43). Satoh J, Andersen M, Bekker Hansen B, Larsen Thorsted B, Tutkunkardas D, Zacho M, Maegawa H. PLoS One; 2018 Aug; 13(9):e0198160. PubMed ID: 30226870 [Abstract] [Full Text] [Related]
23. Glycaemic control and treatment of type 2 diabetes in adults aged 75 years or older. Rodriguez-Poncelas A, Barrot-de la-Puente J, Coll de Tuero G, López-Arpí C, Vlacho B, Lopéz-Simarro F, Mundet Tudurí X, Franch-Nadal J. Int J Clin Pract; 2018 Mar; 72(3):e13075. PubMed ID: 29512235 [Abstract] [Full Text] [Related]
24. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study. Wan KS, Moy FM, Mohd Yusof K, Mustapha FI, Mohd Ali Z, Hairi NN. PLoS One; 2020 Mar; 15(10):e0240531. PubMed ID: 33035261 [Abstract] [Full Text] [Related]
25. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study. Mathur R, Farmer RE, Eastwood SV, Chaturvedi N, Douglas I, Smeeth L. PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037 [Abstract] [Full Text] [Related]
26. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Raebel MA, Ellis JL, Schroeder EB, Xu S, O'Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Steiner JF. Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086 [Abstract] [Full Text] [Related]
28. Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT-Q Study. Bashir M, Thani NA, Khalid A, Khalil O, Alamer Z, Hamad MK, Karuppasamy G, Abufaeid M, Elbidairi M, Al-Mohnnadi D, Elhadd T, Zirie M. Endocrinol Diabetes Metab; 2024 Jul; 7(4):e00495. PubMed ID: 38844642 [Abstract] [Full Text] [Related]
29. Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records. Arnold RJG, Yang S, Gold EJ, Farahbakhshian S, Sheehan JJ. PLoS One; 2018 Jul; 13(6):e0199011. PubMed ID: 29894495 [Abstract] [Full Text] [Related]
30. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies. Liatis S, Iraklianou S, Kazakos K, Mastorakos G, Milios K, Mouslech Z, Noutsou M, Pagkalos E, Sampanis C, AGREEMENT Investigators. BMC Endocr Disord; 2019 Apr 25; 19(1):39. PubMed ID: 31023374 [Abstract] [Full Text] [Related]
32. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain. Conthe P, Mata M, Orozco D, Pajuelo F, Barreto CS, Anaya SF, Gomis R. Diabetes Res Clin Pract; 2011 Jan 25; 91(1):108-14. PubMed ID: 21035225 [Abstract] [Full Text] [Related]
33. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial. Miser WF, Arakaki R, Jiang H, Scism-Bacon J, Anderson PW, Fahrbach JL. Clin Ther; 2010 May 25; 32(5):896-908. PubMed ID: 20685497 [Abstract] [Full Text] [Related]
34. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study. Zhang B, Zhao J, Yang W, Lantus Registry Study Group. Diabetes Metab Res Rev; 2017 Mar 25; 33(3):. PubMed ID: 27667797 [Abstract] [Full Text] [Related]
35. Early treatment with dipeptidyl-peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score-matched cohort study. Cheung JTK, Yang A, Wu H, Lau ESH, Kong APS, Ma RCW, Luk AOY, Chan JCN, Chow E. Diabetes Metab Res Rev; 2024 Jan 25; 40(1):e3711. PubMed ID: 37634071 [Abstract] [Full Text] [Related]
36. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales. Datta-Nemdharry P, Thomson A, Beynon J, Donegan K. Pharmacoepidemiol Drug Saf; 2017 Feb 25; 26(2):127-135. PubMed ID: 27642000 [Abstract] [Full Text] [Related]
37. National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance. Gilstrap LG, Mehrotra A, Bai B, Rose S, Blair RA, Chernew ME. Diabetes Care; 2018 Aug 25; 41(8):1776-1782. PubMed ID: 29794151 [Abstract] [Full Text] [Related]
38. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Diabetes Care; 2013 Nov 25; 36(11):3411-7. PubMed ID: 23877982 [Abstract] [Full Text] [Related]
40. Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study. Koye DN, Montvida O, Paul SK. Drugs; 2020 Apr 25; 80(5):477-487. PubMed ID: 32141024 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]